Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjuna Singanayagam

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|April 19, 2021
Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic TargetingArjuna Singanayagam, Evangelos Triantafyllou
Current Opinion in Critical Care|February 18, 2015
Update on acute liver failureArjuna Singanayagam, William Bernal
Clinical Medicine (London, England)|September 16, 2020
Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosisCharlotte Woodhouse, Arjuna Singanayagam, Vishal C Patel
Intensive Care Medicine|June 7, 2014
Understanding infection susceptibility in patients with acute-on-chronic liver failureNowlan Selvapatt, Arjuna Singanayagam, Julia Wendon, et al.
Immunotherapy|June 13, 2015
Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failureChristine Bernsmeier, Arjuna Singanayagam, Vishal C Patel, et al.
Journal of Critical Care|August 28, 2017
Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failureCaleb Fisher, Vishal C Patel, Sidsel Hyldgaard Stoy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 17, 2018
In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosisTon Lisman, Simone Kleiss, Vishal C Patel, et al.
Ebiomedicine|November 4, 2019
CD8<sup>+</sup>T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunctionFanny Lebossé, Cathrin Gudd, Enes Tunc, et al.
Gut|June 9, 2017
CD14<sup>+</sup> CD15<sup>-</sup> HLA-DR<sup>-</sup> myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failureChristine Bernsmeier, Evangelos Triantafyllou, Robert Brenig, et al.
Gastro Hep Advances|August 12, 2024
Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver FailureSofia Roth, Emilio Flint, Lea Ghataore, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|April 19, 2021
Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic TargetingArjuna Singanayagam, Evangelos Triantafyllou
Current Opinion in Critical Care|February 18, 2015
Update on acute liver failureArjuna Singanayagam, William Bernal
Clinical Medicine (London, England)|September 16, 2020
Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosisCharlotte Woodhouse, Arjuna Singanayagam, Vishal C Patel
Intensive Care Medicine|June 7, 2014
Understanding infection susceptibility in patients with acute-on-chronic liver failureNowlan Selvapatt, Arjuna Singanayagam, Julia Wendon, et al.
Immunotherapy|June 13, 2015
Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failureChristine Bernsmeier, Arjuna Singanayagam, Vishal C Patel, et al.
Journal of Critical Care|August 28, 2017
Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failureCaleb Fisher, Vishal C Patel, Sidsel Hyldgaard Stoy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 17, 2018
In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosisTon Lisman, Simone Kleiss, Vishal C Patel, et al.
Ebiomedicine|November 4, 2019
CD8<sup>+</sup>T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunctionFanny Lebossé, Cathrin Gudd, Enes Tunc, et al.
Gut|June 9, 2017
CD14<sup>+</sup> CD15<sup>-</sup> HLA-DR<sup>-</sup> myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failureChristine Bernsmeier, Evangelos Triantafyllou, Robert Brenig, et al.
Gastro Hep Advances|August 12, 2024
Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver FailureSofia Roth, Emilio Flint, Lea Ghataore, et al.
Pageof 2